e8vk
 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 6, 2004

United Therapeutics Corporation
(Exact Name of Registrant as Specified in Charter)

         
Delaware   000-26301   52-1984749
(State or Other   (Commission   (I.R.S. Employer
Jurisdiction of   File Number)   Identification Number)
Incorporation)        
     
1110 Spring Street    
Silver Spring, MD   20910
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code:

(301) 608-9292

 


 

Item 12. Earnings Announcements or Releases.

On May 6, 2004, United Therapeutics Corporation (the “Company”) issued a press release setting forth its earnings for the Company’s quarterly fiscal period ended March 31, 2004. A copy of this press release is attached hereto as Exhibit 99.1. The Company does not intend for Exhibit 99.1 to be incorporated by reference into filings under the Securities Act of 1933 or the Securities Exchange Act of 1934.

Item 7. Exhibits

     (c) Exhibits

     
Exhibit No.  
Description of Exhibit
     
99.1
  Press release dated May 6, 2004

 


 

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                 
            UNITED THERAPEUTICS CORPORATION
                 
                 
Dated: May 6, 2004
      By:   /s/ Paul A. Mahon

Name: Paul A. Mahon
Title: General Counsel

 


 

EXHIBIT INDEX

     
Exhibit No.   Description of Exhibit  
     
99.1
  Press release dated May 6, 2004